The Fed Could Crush Trump’s Bull Market — Here’s the Warning Wall Street Is Missing 24/7 Wall St. · Finance 16m ago
Mirum Pharma's Phase 2b Study Of Volixibat For Sclerosing Cholangitis Meets End Point, Shares Gain NASDAQ · Markets 19m ago
Lazard profit soars 67% in Q1 2026 on asset management growth Private Banker International · Finance 21m ago